Clinical trial
A Clinical Trial to Evaluate the Efficacy and Safety of Hydrogen-oxygen Mixed Gas Inhalation in Convalescent Severe/Critically Ill Patients With Novel Coronavirus Pneumonia (COVID-19)
NCT04594460 is registered in ClinicalTrials.gov with Guangzhou Institute of Respiratory Disease as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Trial to Evaluate the Efficacy and Safety of Hydrogen-oxygen Mixed Gas Inhalation in Convalescent Severe/Critically Ill Patients With Novel Coronavirus Pneumonia (COVID-19)
- Lead sponsor
- Guangzhou Institute of Respiratory Disease
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 31, 2020
- Completion date
- December 31, 2021
- Enrollment
- 198 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
ams-h-03, covid19, hydrogen-oxygen gas